Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients

Bone Marrow Transplant. 1996 Nov;18(5):969-73.

Abstract

Six patients who were seronegative to measles after autologous bone marrow transplantation (ABMT) were vaccinated with a live attenuated measles vaccine. The specific T helper cell response was studied by measuring lymphocyte proliferation induced by measles antigen and B cell response by measles specific IgG by ELISA. Blood samples were drawn before, at 1-3 months, and at 1 year after vaccination. It was found that a pre-existing T cell response correlated with an impaired B cell response 1 year after vaccination (r = 0.83, P = 0.04), whereas no correlation was found between IgG titers before vaccination and IgG titer increase, or T cell response after vaccination. Furthermore, there was a transient negative correlation between the T cell response at 1-3 months after vaccination and the T cell response before vaccination (r = -0.90, P = 0.04) that became positive at 1 year after vaccination (r = 0.90, P = 0.02). In conclusion, in patients seronegative to measles who were revaccinated with measles vaccine after ABMT, a pre-existing T cell response correlated with an impaired B cell response, while pre-existing low-level IgG antibodies had no significant influence on the IgG titer rise. A sustained T cell response to measles antigen before vaccination may thus be one possible explanation for measles vaccine failure in ABMT patients.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation* / adverse effects
  • Bone Marrow Transplantation* / immunology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunity, Cellular / drug effects*
  • Male
  • Measles / immunology
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage*
  • Measles Vaccine / immunology
  • Measles virus*
  • T-Lymphocytes / immunology*
  • Transplantation, Autologous

Substances

  • Measles Vaccine